| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.43 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |